Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Total Voting Rights

30 Dec 2014 07:00

RNS Number : 8604A
Fitbug Holdings PLC
30 December 2014
 



Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

30 December 2014

Fitbug Holdings plc ('Fitbug' or 'the Company')

Total Voting Rights

 

Further to the announcement of 9 December 2014, Fitbug Holdings Plc, the AIM quoted provider of online personal health and wellbeing services, is pleased to confirm that the 39,002,224 Placing Shares and 33,333,333 Loan Conversion Shares have now been admitted to trading on AIM, effective 30 December 2014.

 

Fergus Kee, Executive Chairman, said, "I would like to take this opportunity to welcome new shareholders to the Company and thank existing investors for their continued support. With the help of these funds and strong prospects, I believe that Fitbug is now entering a very exciting period as we start the new year."

 

Following Admission of the Placing Shares and Loan Conversion Shares, for the purposes of the FCA's Disclosure and Transparency Rules, the Company advises that the total number of shares in issue and total voting rights will be 240,850,530 Ordinary Shares of 1 pence each.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.

 

Upon Admission, the Placing Shares will represent 16.19 per cent. and the Loan Conversion Shares 13.84 per cent. of the enlarged share capital. The Placing Shares and Loan Conversion Shares will rank pari passu with the existing Ordinary Shares, including the right to all dividends and other distributions, paid or made after the date of issue.

 

Following the Admission of these shares to AIM, the directors below now hold the following shares in the Company:

 

Shareholder No. of Shares % of issued share capital

 

Fergus Kee 22,916,667 9.51%

David Turner* 12,515,000 5.20%

Allan Fisher** 10,890,000 4.52%

Paul Landau 8,788,894 3.65%

 

* Persons connected with David Turner have an interest in 6,280,000 ordinary shares representing 2.61 per cent. of the issued share capital of the Company

** Persons connected with Allan Fisher have an interest in 6,280,000 ordinary shares representing 2.61 per cent. of the issued share capital of the Company

 

**ENDS**

 

For further information visit www.kiqplan.com or www.fitbugholdings.com contact:

 

Paul Landau/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce / William Lynne / Niall Pearson

Hybridan LLP, Broker and advisor to the placing

0203 713 4580/4582/4583

Elisabeth Cowell/Charlotte Heap

St Brides Media & Finance Ltd

020 7236 1177

 

 

 

Notes

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement. Its "Kiqplan"TM digital health coaching platform is designed to make wearable technology relevant to new audiences and take the "so what?" out of activity tracking by providing structured action plans to help people get fitter, lighter and lead happier, healthier lives.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes, fitness operators and consumers. Increasingly, Fitbug's platforms act as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes. An important part of the Company's focus is on building strategic partnerships with organisations which can integrate Fitbug into their own service/product offerings or resell to their customer base. The Company has operations in the UK, Australia and Asia, with the United States remaining the primary market. For more information, visit www.fitbug.com and wwwkiqplan.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRPGGAWPUPCGAB
Date   Source Headline
17th Aug 20204:36 pmRNSPrice Monitoring Extension
14th Aug 20204:40 pmRNSSecond Price Monitoring Extn
14th Aug 20204:35 pmRNSPrice Monitoring Extension
21st Jul 20207:00 amRNSTrading Update
16th Jun 20207:00 amRNSBidstack receives IAB Gold Standard certificate
11th Jun 202011:39 amRNSTR1: Notification of major holdings
10th Jun 20208:57 amRNSDirector/PDMR Shareholdings
5th Jun 202011:05 amRNSSecond Price Monitoring Extn
5th Jun 202011:00 amRNSPrice Monitoring Extension
5th Jun 20209:05 amRNSSecond Price Monitoring Extn
5th Jun 20209:00 amRNSPrice Monitoring Extension
5th Jun 20207:00 amRNSResults of Placing and Subscription
4th Jun 20204:55 pmRNSProposed fundraise of a minimum of £5 million
28th May 20204:13 pmRNSAnnual General Meeting Results
28th May 20207:00 amRNSAGM Statement
12th May 20204:40 pmRNSSecond Price Monitoring Extn
12th May 20204:35 pmRNSPrice Monitoring Extension
11th May 20204:42 pmRNSSecond Price Monitoring Extn
11th May 20204:36 pmRNSPrice Monitoring Extension
11th May 20202:05 pmRNSSecond Price Monitoring Extn
11th May 20202:00 pmRNSPrice Monitoring Extension
11th May 20207:00 amRNSCollaboration with Codemasters for DIRT 5
6th May 20203:23 pmRNS2019 Report and Accounts & AGM Notice posted
5th May 20202:05 pmRNSSecond Price Monitoring Extn
5th May 20202:00 pmRNSPrice Monitoring Extension
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:35 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSPreliminary Results for the year ended 31 Dec 2019
27th Apr 20204:20 pmRNSFurther details re Lumen Research Study
24th Apr 20204:41 pmRNSSecond Price Monitoring Extn
24th Apr 20204:36 pmRNSPrice Monitoring Extension
17th Apr 20207:00 amRNSIndependent Research Report
15th Apr 20204:41 pmRNSSecond Price Monitoring Extn
15th Apr 20204:36 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSUK Government’s “Stay Home Save Lives” campaign
30th Mar 20204:41 pmRNSSecond Price Monitoring Extn
30th Mar 20204:37 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSCOVID-19 Business Update
25th Mar 202010:48 amRNSPartnership with Gfinity and Venatus
17th Mar 20202:06 pmRNSSecond Price Monitoring Extn
17th Mar 20202:00 pmRNSPrice Monitoring Extension
16th Mar 20202:06 pmRNSSecond Price Monitoring Extn
16th Mar 20202:01 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSBidstack and Codemasters New Gaming Collaboration
14th Feb 20204:40 pmRNSSecond Price Monitoring Extn
14th Feb 20204:35 pmRNSPrice Monitoring Extension
13th Feb 20202:05 pmRNSSecond Price Monitoring Extn
13th Feb 20202:00 pmRNSPrice Monitoring Extension
12th Feb 202011:05 amRNSSecond Price Monitoring Extn
12th Feb 202011:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.